Contact
searchSearch
HMP Global

Pediatric Dermatology

Featured

FDA Alerts
FDA Approves Vyjuvek for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
08/10/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug...
08/10/2023
The Dermatologist
News
Patients With Pediatric Granuloma Annulare Often Present With Asthma and Atopy
01/31/2023
Lisa Kuhns, PhD, MD
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a...
01/31/2023
The Dermatologist
CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
News
Tobacco Exposure Linked to Childhood Psoriasis
12/23/2021
Lauren Mateja
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology...
12/23/2021
The Dermatologist
News
Paraben Exposure Increases Atopic Dermatitis Prevalence in Young Children
12/18/2021
Lisa Kuhns, PhD, MD
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in...
12/18/2021
The Dermatologist
News
Atopic Dermatitis Associated With Shorter Stature and Higher BMI in Children
12/13/2021
Lisa Kuhns, PhD, MD
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is...
12/13/2021
The Dermatologist
News
Pediatric Urticaria Resolution Associated With Elevated CD63 Levels and Thyroid Comorbidity
04/13/2021
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid...
04/13/2021
The Dermatologist
News
Metabolic Syndrome and Insulin Resistance Found in Pre-Pubertal Children With Psoriasis
01/29/2021
A high prevalence of metabolic syndrome (MetS) and insulin resistance exists in pre-pubertal children with psoriasis, according to a recent publication in the European Journal of Pediatrics.
A high prevalence of metabolic syndrome (MetS) and insulin resistance exists in pre-pubertal children with psoriasis, according to a recent publication in the European Journal of Pediatrics.
A high prevalence of metabolic...
01/29/2021
The Dermatologist
News
Itch NRS Suitable for Pediatric Psoriasis Population
01/04/2021
Use of the Itch Numeric Rating Scale (NRS) in adults with psoriasis is common, but standard use in a similar pediatric population has not been established. A qualitative study supports the content validity of the Itch NRS for pediatric...
Use of the Itch Numeric Rating Scale (NRS) in adults with psoriasis is common, but standard use in a similar pediatric population has not been established. A qualitative study supports the content validity of the Itch NRS for pediatric...
Use of the Itch Numeric Rating...
01/04/2021
The Dermatologist
Q&As
Amplifying the Voice of Women in Pediatric Dermatology
12/14/2020
Lauren Mateja
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
...
12/14/2020
The Dermatologist

Expert Insights

CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
Q&As
Amplifying the Voice of Women in Pediatric Dermatology
12/14/2020
Lauren Mateja
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
...
12/14/2020
The Dermatologist
eee
Podcasts
Dr Heath Shares Clinical Pearls for Treating Pediatric Patients
10/02/2020
Candrice Heath, MD, shared her insights on treating pediatric patients, and why it is important for all dermatologists, including those who only see adults, to learn about treating younger patients.
Candrice Heath, MD, shared her insights on treating pediatric patients, and why it is important for all dermatologists, including those who only see adults, to learn about treating younger patients.
Candrice Heath, MD, shared her...
10/02/2020
The Dermatologist
Cover Story
More to Skin Than Meets the Eye: Bullying and Childhood Skin Conditions
09/11/2020
Sasha D. Jaquez, PhD; Maria A. Leszczynska, MD
Bullying is common in childhood, and children with visible skin conditions can be highly vulnerable. Dermatologists can play a critical role into helping their pediatric patients through early screening and management.
Bullying is common in childhood, and children with visible skin conditions can be highly vulnerable. Dermatologists can play a critical role into helping their pediatric patients through early screening and management.
Bullying is common in childhood,...
09/11/2020
The Dermatologist
Feature Story
Treating Molluscum Contagiosum: Current Choices vs the Future Pipeline
02/13/2020
Without approved treatment options for molluscum contagiosum, doctors have differing opinions on how and even whether to treat. Recent interviews with dermatologists and pediatricians offer insight into the treatments that these two...
Without approved treatment options for molluscum contagiosum, doctors have differing opinions on how and even whether to treat. Recent interviews with dermatologists and pediatricians offer insight into the treatments that these two...
Without approved treatment...
02/13/2020
The Dermatologist
Asempa
Videos
Myth Buster: Shared Decision-Making is Easy in Alopecia Areata
08/06/2026
Oyetewa Boluwatito Asempa, MD, FAAD; Riya Gandhi, MA
Shared decision-making in alopecia areata is often more complex than it appears. Dr Oyetewa Asempa discusses aligning treatment goals, managing expectations, and improving patient-clinician communication.
Shared decision-making in alopecia areata is often more complex than it appears. Dr Oyetewa Asempa discusses aligning treatment goals, managing expectations, and improving patient-clinician communication.
Shared decision-making in...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Hair Regrowth is the Only Outcome That Matters
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Hair regrowth is only one measure of success in alopecia areata. Dr Zoe Draelos highlights patient-centered outcomes, quality of life, emotional well-being, and long-term disease control.
Hair regrowth is only one measure of success in alopecia areata. Dr Zoe Draelos highlights patient-centered outcomes, quality of life, emotional well-being, and long-term disease control.
Hair regrowth is only one...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Children are More Resilient to Alopecia Areata Than Adults
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Pediatric alopecia areata can have profound emotional and social consequences. Dr Zoe Draelos examines the unique psychological challenges facing children and adolescents with the disease.
Pediatric alopecia areata can have profound emotional and social consequences. Dr Zoe Draelos examines the unique psychological challenges facing children and adolescents with the disease.
Pediatric alopecia areata can...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Patients Will Adjust to Alopecia Areata Over Time
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Adapting to alopecia areata isn't always a linear process. Dr Zoe Draelos discusses the lasting emotional impact of the disease and why ongoing psychosocial support remains essential.
Adapting to alopecia areata isn't always a linear process. Dr Zoe Draelos discusses the lasting emotional impact of the disease and why ongoing psychosocial support remains essential.
Adapting to alopecia areata...
08/06/2026
The Dermatologist
Asempa
Videos
Myth Buster: Dermatologists are Already Addressing the Psychosocial Burden of Alopecia Areata
08/06/2026
Oyetewa Boluwatito Asempa, MD, FAAD; Riya Gandhi, MA
Treating alopecia areata extends beyond managing hair loss. Dr Oyetewa Asempa explores gaps in psychosocial care, patient communication, and integrating mental health into clinical practice.
Treating alopecia areata extends beyond managing hair loss. Dr Oyetewa Asempa explores gaps in psychosocial care, patient communication, and integrating mental health into clinical practice.
Treating alopecia areata extends...
08/06/2026
The Dermatologist
Guttman
Videos
Myth Buster: If Treatment is Working, Patients can Stop it Immediately
08/06/2026
Emma Guttman-Yassky, MD, PhD; Riya Gandhi, MA
Successful alopecia areata treatment doesn't always mean therapy should end. Dr Emma Guttman discusses relapse risk, maintenance strategies, and setting realistic expectations for long-term disease management.
Successful alopecia areata treatment doesn't always mean therapy should end. Dr Emma Guttman discusses relapse risk, maintenance strategies, and setting realistic expectations for long-term disease management.
Successful alopecia areata...
08/06/2026
The Dermatologist
Emma Guttman
Videos
Myth Buster: Once a Patient Loses all Their Hair, Treatment Won’t Work
08/06/2026
Emma Guttman-Yassky, MD, PhD; Riya Gandhi, MA
Complete hair loss doesn't necessarily mean treatment failure in alopecia areata. Examine the latest evidence on therapeutic response, severe disease, and evolving treatment strategies.
Complete hair loss doesn't necessarily mean treatment failure in alopecia areata. Examine the latest evidence on therapeutic response, severe disease, and evolving treatment strategies.
Complete hair loss doesn't...
08/06/2026
The Dermatologist
Guttman
Videos
Myth Buster: Alopecia Areata is Just Hair Loss
08/06/2026
Emma Guttman-Yassky, MD, PhD; Riya Gandhi, MA
Alopecia areata is more than hair loss. Dr Emma Guttman discusses the disease's psychosocial burden, autoimmune nature, and why viewing AA as purely cosmetic can undermine patient care.
Alopecia areata is more than hair loss. Dr Emma Guttman discusses the disease's psychosocial burden, autoimmune nature, and why viewing AA as purely cosmetic can undermine patient care.
Alopecia areata is more than...
08/06/2026
The Dermatologist
Craiglow
Videos
Myth Buster: Alopecia Areata is No Longer an Unmet Need in Dermatology
08/06/2026
Brittany Craiglow, MD; Riya Gandhi, MA
Despite major therapeutic advances, alopecia areata remains an area of unmet need. Dr Brittany Craiglow explores ongoing challenges in treatment access, research, and long-term disease management.
Despite major therapeutic advances, alopecia areata remains an area of unmet need. Dr Brittany Craiglow explores ongoing challenges in treatment access, research, and long-term disease management.
Despite major therapeutic...
08/06/2026
The Dermatologist
Craiglow
Videos
Myth Buster: Alopecia Areata Awareness has Solved the Stigma Problem
08/06/2026
Brittany Craiglow, MD; Riya Gandhi, MA
Growing awareness of alopecia areata has improved visibility, but stigma remains. Dr Brittany Craiglow discusses persistent misconceptions, social challenges, and opportunities for better patient support.
Growing awareness of alopecia areata has improved visibility, but stigma remains. Dr Brittany Craiglow discusses persistent misconceptions, social challenges, and opportunities for better patient support.
Growing awareness of alopecia...
08/06/2026
The Dermatologist

News and Quizzes

FDA Alerts
FDA Approves Vyjuvek for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
08/10/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug...
08/10/2023
The Dermatologist
News
Patients With Pediatric Granuloma Annulare Often Present With Asthma and Atopy
01/31/2023
Lisa Kuhns, PhD, MD
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a...
01/31/2023
The Dermatologist
News
Tobacco Exposure Linked to Childhood Psoriasis
12/23/2021
Lauren Mateja
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology...
12/23/2021
The Dermatologist
News
Paraben Exposure Increases Atopic Dermatitis Prevalence in Young Children
12/18/2021
Lisa Kuhns, PhD, MD
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in...
12/18/2021
The Dermatologist
News
Atopic Dermatitis Associated With Shorter Stature and Higher BMI in Children
12/13/2021
Lisa Kuhns, PhD, MD
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is...
12/13/2021
The Dermatologist
News
Pediatric Urticaria Resolution Associated With Elevated CD63 Levels and Thyroid Comorbidity
04/13/2021
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid...
04/13/2021
The Dermatologist
FDA Alerts
FDA Grants Accelerated Approval to Tudriqev for PD-1-Refractory Advanced Melanoma
08/07/2026
Jessica Garlewicz
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug...
08/07/2026
The Dermatologist
roflum
FDA Alerts
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2 Years
06/30/2026
Riya Gandhi, MA
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes...
06/30/2026
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
FDA Alert
FDA Alerts
FDA Approves Every-8-Week Maintenance Dosing Option for Lebrikizumab in Atopic Dermatitis
06/10/2026
Jessica Garlewicz
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week...
06/10/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
July/August 2026

Current Issue

August 2026
Volume 34
Issue 5
Current Issue
Issue Archive
The Dermatologist Newsletter

Recent News

FDA Alerts
FDA Approves Vyjuvek for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
08/10/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug...
08/10/2023
The Dermatologist
News
Patients With Pediatric Granuloma Annulare Often Present With Asthma and Atopy
01/31/2023
Lisa Kuhns, PhD, MD
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a...
01/31/2023
The Dermatologist
News
Tobacco Exposure Linked to Childhood Psoriasis
12/23/2021
Lauren Mateja
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology...
12/23/2021
The Dermatologist
News
Paraben Exposure Increases Atopic Dermatitis Prevalence in Young Children
12/18/2021
Lisa Kuhns, PhD, MD
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in...
12/18/2021
The Dermatologist
News
Atopic Dermatitis Associated With Shorter Stature and Higher BMI in Children
12/13/2021
Lisa Kuhns, PhD, MD
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is...
12/13/2021
The Dermatologist
News
Pediatric Urticaria Resolution Associated With Elevated CD63 Levels and Thyroid Comorbidity
04/13/2021
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid...
04/13/2021
The Dermatologist
FDA Alerts
FDA Grants Accelerated Approval to Tudriqev for PD-1-Refractory Advanced Melanoma
08/07/2026
Jessica Garlewicz
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug...
08/07/2026
The Dermatologist
roflum
FDA Alerts
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2 Years
06/30/2026
Riya Gandhi, MA
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes...
06/30/2026
The Dermatologist
FDA Alert
FDA Alerts
FDA Approves Every-8-Week Maintenance Dosing Option for Lebrikizumab in Atopic Dermatitis
06/10/2026
Jessica Garlewicz
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week...
06/10/2026
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
AD
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
random
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use